Day: April 2, 2020

Hermed indkaldes til fælles ordinær generalforsamling i Investeringsforeningen Formuepleje, Kapitalforeningerne Formuepleje Epikur, Formuepleje Fokus, Formuepleje Merkur, Formuepleje Pareto, Formuepleje Penta og Formuepleje Safe tirsdag den 28. april 2020 kl. 13.00 hos Formuepleje A/S, Værkmestergade 25, 15. sal, 8000 Aarhus C.På grund af situationen omkring Coronavirus opfordrer bestyrelsen til, at investorerne holder sig ajourført med sundhedsmyndighedernes anbefalinger, og i stedet i videst muligt omfang udøver deres stemmerettigheder ved at anvende fuldmagt. Hvis det på grund af forsamlingsforbud eller andre retningslinjer fra myndighederne ikke er muligt at gennemføre generalforsamlingen med fysisk fremmøde, vil der blive mulighed for at deltage gennem en digital løsning med lyd og billede. Såfremt dette bliver nødvendigt, vil yderligere...

Price point of this high-volume laboratory version test is expected be as low as $10 per patient Once developed and scaled-up, Biomerica’s existing production capacity could allow for over 1,000,000 tests per month at its manufacturing facilities in Irvine, California  IRVINE, Calif., April 02, 2020 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) today announced it has signed two separate definitive license agreements with Mount Sinai’s Icahn School of Medicine in New York to license technologies pertaining to a laboratory version serological test for SARS-CoV-2 (“COVID-19”) virus infection which have been developed at Mount Sinai. This test uses the ELISA microplate format that can run on existing open system equipment found in most hospitals and clinical laboratories in the United States.Biomerica has extensive serological test...

Hermed indkaldes til fælles ordinær generalforsamling i Investeringsforeningen Formuepleje, Kapitalforeningerne Formuepleje Epikur, Formuepleje Fokus, Formuepleje Merkur, Formuepleje Pareto, Formuepleje Penta og Formuepleje Safe tirsdag den 28. april 2020 kl. 13.00 hos Formuepleje A/S, Værkmestergade 25, 15. sal, 8000 Aarhus C.På grund af situationen omkring Coronavirus opfordrer bestyrelsen til, at investorerne holder sig ajourført med sundhedsmyndighedernes anbefalinger, og i stedet i videst muligt omfang udøver deres stemmerettigheder ved at anvende fuldmagt. Hvis det på grund af forsamlingsforbud eller andre retningslinjer fra myndighederne ikke er muligt at gennemføre generalforsamlingen med fysisk fremmøde, vil der blive mulighed for at deltage gennem en digital løsning med lyd og billede. Såfremt dette bliver nødvendigt, vil yderligere...

TORONTO, April 02, 2020 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”), in accordance with the blanket relief of a 45-day extension, provided by Canadian Securities Administrators and Ontario Instrument 51-502: Temporary Exemption from Certain Corporate Finance Requirements, for periodic filings normally required to be made by issuers during the period from March 23, 2020 to June 1, 2020, announces that it was unable to file its audited annual financial statements for the year ended December 31, 2019 and the related management’s discussion and analysis and Annual Information Form, as required by Part 4 and Part 5 of National Instrument 51-102: Continuous Disclosure Obligations (collectively, the “Annual Filings”) by the filing deadline of March 30, 2020. The...

RICHMOND HILL, Ontario, April 02, 2020 (GLOBE NEWSWIRE) — Helix BioPharma Corp. (TSX: HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today provides a corporate update.COVID-19As countries across the globe face an unprecedented public health crisis due to COVID-19, Helix has taken various measures to protect the health and well-being of our staff while maintaining business continuity.The office and laboratory of Helix in Canada have been following the recommendations of federal, provincial and regional authorities.  This includes operating a safe and clean working environment, providing work at home facility and observing latest public health guidance such as ‘social distancing’.  Except for a limited number of staff at the laboratory to...

Anticipates $2.6 Million Net Revenues, Approximately 45% Growth Over 2019SOUTH ORANGE, NJ, April 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced preliminary financial results for the quarter ended March 31, 2020.Net revenues are expected to be $2.6 million, an increase of approximately 45% compared to the quarter ended March 31, 2019.“In this unprecedented time of crisis, we are pleased that the company’s growth continued in the first quarter,” said Daron Evans, President and CEO of Nephros. “These results represent our 15th consecutive quarter of year-on-year sales growth, with a current average of 62%. While the coronavirus...

DEVOTE will evaluate the safety and potential for even greater efficacy of a higher dose of SPINRAZA in the treatment of spinal muscular atrophy (SMA)Well-established safety profile and proven efficacy of SPINRAZA in a broad range of patients supports exploration of the higher doseBiogen continues to invest in SPINRAZA clinical development and ongoing research in SMA, for which there is currently no cureCAMBRIDGE, Mass., April 02, 2020 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced that the first patient has been treated in the global clinical study, DEVOTE. The study is designed to evaluate the safety, tolerability and potential for even greater efficacy of SPINRAZA (nusinersen) when administered at a higher dose than currently approved for the treatment of spinal muscular atrophy (SMA). The Phase 2/3 randomized, controlled,...

WASHINGTON, April 02, 2020 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today released the findings of its 2020 U.S. Loan Market Survey, which provides a glimpse into bank and non-bank lenders’ views against the backdrop of the COVID-19 pandemic and oil market price disruptions.According to the survey, which was conducted from Feb. 19 to March 6, just as the pandemic was gaining hold in the United States, 53% of bank and non-bank lenders in the U.S. market viewed COVID-19 as an event more significant than global financial markets were expecting, and 19% viewed it as something capable of triggering a global recession that markets were too complacent about.“The hugely disruptive economic effects of COVID-19 in the U.S. are manifest today, but it wasn’t obvious at all six weeks ago when our survey was launched,” said Sanjeev...

CAMBRIDGE, Mass., April 02, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today provided an update on the Company’s clinical trial activities and business operations in light of  the COVID-19 pandemic.“The COVID-19 pandemic has greatly impacted the global healthcare system. During these challenging times, our utmost priority is the health and safety of patients in our clinical studies and the healthcare professionals who care for them, as well as our team. To that end, we have implemented measures to protect their well-being while ensuring our ability to maintain the continuity of our business,” said Craig Wheeler, President and Chief Executive Officer at Momenta Pharmaceuticals....

NEW YORK, NY, April 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – Global Arena Holding, Inc. (the “Company”) (OTC PINK: GAHC), in response to a number of shareholder inquiries about mail ballots and how the process works, is pleased to discuss the proprietary Registration Process that GAHC subsidiary, Global Election Services, Inc. (GES), employed in the North Dakota Democratic-NPL Presidential Primary. In our next update, we will discuss our proprietary Tabulation Software System Process. The GES senior management team has four decades of experience in administering successful elections. Each election process is tailored to fit the individual client’s needs while complying with the US Department of Labor Election Standards, which organized labor unions are required to uphold. GES works individually with each client to develop...